Richard Furie, MD, surveys changes he has witnessed to the therapeutic landscape for the treatment of systemic lupus erythematosus (SLE), including the introduction of agents such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback